ARCHIVES

Amgen Cancels Rilotumumab Trials in Gastric Cancer

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

In Congress: Could NCI Make Use Of Increase? Porter Asks; “We Can Handle It Well,” Klausner Replies

April 3, 1998

Caris Officials Respond To Questions Submitted By The Cancer Letter

August 8, 2014

In Brief: One More Committee Review Needed for L.A., Rhode Island; Animal Tests In Factories (?)

May 13, 1977

DRCCA Organization To Include Three Programs, With Centers In One

August 8, 1980

Cyclamate Committee Finds No Proof Of Carcinogenicity

January 23, 1976

President, Congress, Cancer Letter Take Off

August 22, 1986